Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib Supplementary Material
posted on 2023-03-31, 15:30authored byPaul K Paik, Ravi K Goyal, Beilei Cai, Mark A Price, Keith L Davis, Valerie Derrien Ansquer, Nydia Caro, Teddy R Saliba
Real-world outcomes in non-small-cell lung cancer patients with MET Exon 14 skipping mutation and brain metastases treated with capmatinib Supplementary Material